OmniAb (OABI) Change in Acquisitions & Divestments (2022 - 2025)
OmniAb (OABI) reported Change in Acquisitions & Divestments of -$39.7 million for Q4 2025, down 373.86% year-over-year from $14.5 million in Q4 2024, and down 200.0% quarter-over-quarter from $39.7 million in Q3 2025.
OmniAb (OABI) Change in Acquisitions & Divestments (2022 - 2025) Analysis & Trends
OmniAb (OABI) has 4 years of Change in Acquisitions & Divestments data on file, last reported at -$39.7 million in Q4 2025.
- Change in Acquisitions & Divestments for Q4 2025 came in at -$39.7 million, down 373.86% year-over-year; the trailing twelve-month figure through Mar 2026 was -$9.4 million (down 115.3% YoY), and the FY2025 annual result was $90000.0, down 99.88% from the prior year.
- Change in Acquisitions & Divestments fell to -$39.7 million in Q4 2025 per OABI's latest filing, from $39.7 million in the prior quarter.
- Over five years, Change in Acquisitions & Divestments peaked at $62.2 million in Q3 2024 and troughed at -$39.7 million in Q4 2025.
- A 4-year average of $6.3 million and a median of $4.0 million in 2023 frame the typical range for Change in Acquisitions & Divestments.
- The sharpest annual moves came in 2024 and 2025: Change in Acquisitions & Divestments soared 1919.5% in 2024, then tumbled 373.86% in 2025.
- A 4-year view of Change in Acquisitions & Divestments shows it stood at $70000.0 in 2022, then soared by 925.71% to $718000.0 in 2023, then soared by 1919.5% to $14.5 million in 2024, then tumbled by 373.86% to -$39.7 million in 2025.
- Business Quant data shows OABI's Change in Acquisitions & Divestments at -$39.7 million in Q4 2025, $39.7 million in Q3 2025, and -$9.4 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | OmniAb | 294.96 Mn | 252.00 Mn | 14.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -39.71 Mn |
| Dec 31, 2025 | -39.71 Mn |
| Sep 30, 2025 | 39.71 Mn |
| Sep 30, 2025 | 39.71 Mn |
| Jun 30, 2025 | -9.41 Mn |
| Jun 30, 2025 | -9.41 Mn |
| Mar 31, 2025 | 9.50 Mn |
| Mar 31, 2025 | 9.50 Mn |
| Dec 31, 2024 | 14.50 Mn |
| Dec 31, 2024 | 14.50 Mn |
| Sep 30, 2024 | 62.19 Mn |
| Sep 30, 2024 | 62.19 Mn |
| Jun 30, 2024 | -24.69 Mn |
| Jun 30, 2024 | -24.69 Mn |
| Mar 31, 2024 | 26.00 Mn |
| Mar 31, 2024 | 26.00 Mn |
| Dec 31, 2023 | 718,000.00 |
| Dec 31, 2023 | 718,000.00 |
| Sep 30, 2023 | -27.29 Mn |
| Sep 30, 2023 | -27.29 Mn |